JohnLaurielloMD
Psychiatry • Philadelphia, PAProfessor and Chairman, Department of Psychiatry and Human Behavior, Sidney Kimmel Medical College-Jefferson Health
Dr. Lauriello is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
833 Chestnut Street Suite 210
Philadelphia, PA 19118Phone+1 215-955-6913- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1986 - 1990
Lewis Katz School of Medicine at Temple UniversityClass of 1986
Certifications & Licensure
CA State Medical License 1990 - 2025
PA State Medical License 2019 - 2024
MO State Medical License 2009 - 2020
NM State Medical License 1994 - 2010- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Modular EHR, Cerner Corporation, 2013
Clinical Trials
- Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- 8 citationsVariability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.Kate Merritt, Robert A McCutcheon, André Aleman, Sarah Ashley, Katherine Beck, Wolfgang Block, Oswald J N Bloemen, Faith Borgan, Christiana Boules, Juan R Bustillo, Ar...> ;Molecular Psychiatry. 2023 May 1
- 7 citationsSublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial.Leslie Citrome, Sheldon H Preskorn, John Lauriello, John H Krystal, Rishi Kakar, Jeffrey Finman, Michael De Vivo, Frank D Yocca, Robert Risinger, Lavanya Rajachandran> ;The Journal of Clinical Psychiatry. 2022 Oct 3
- 6 citationsReal-World Outcomes and Costs Following 6 Months of Treatment with the Long-Acting Injectable (LAI) Aripiprazole Lauroxil for the Treatment of Schizophrenia.John Lauriello, Peter J. Weiden, Carole D. Gleeson, Ankit Shah, Luke Boulanger, Krutika Jariwala-Parikh, Elizabeth Hedgeman, Amy K O'Sullivan> ;CNS Drugs. 2021 Sep 21
- Join now to see all
Other
- Pharmacotherapy for schizophrenia: Long-acting injectable antipsychotic drugsLauriello J, Campbell AR
http://www.uptodate.com/contents/pharmacotherapy-for-schizophrenia-long-acting-injectable-antipsycho
UpToDate, Wolters Kluwer Health - 2013-02-14
Press Mentions
Aripiprazole Lauroxil Appears to Improve Schizophrenia Symptoms Safely, SignificantlyAugust 26th, 2020
Hospital Affiliations
Thomas Jefferson University HospitalPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
